105 related articles for article (PubMed ID: 2847360)
21. Urodilatin: binding properties and stimulation of cGMP generation in rat kidney cells.
Saxenhofer H; Fitzgibbon WR; Paul RV
Am J Physiol; 1993 Feb; 264(2 Pt 2):F267-73. PubMed ID: 8095370
[TBL] [Abstract][Full Text] [Related]
22. Atriopeptin-induced increases in endothelial cell permeability are associated with elevated cGMP levels.
Yonemaru M; Ishii K; Murad F; Raffin TA
Am J Physiol; 1992 Sep; 263(3 Pt 1):L363-9. PubMed ID: 1329530
[TBL] [Abstract][Full Text] [Related]
23. Expression of guanylyl cyclase-A/atrial natriuretic peptide receptor blocks the activation of protein kinase C in vascular smooth muscle cells. Role of cGMP and cGMP-dependent protein kinase.
Kumar R; Cartledge WA; Lincoln TM; Pandey KN
Hypertension; 1997 Jan; 29(1 Pt 2):414-21. PubMed ID: 9039136
[TBL] [Abstract][Full Text] [Related]
24. Endothelin-1 production by rat inner medullary collecting duct: effect of nitric oxide, cGMP, and immune cytokines.
Kohan DE; Padilla E
Am J Physiol; 1994 Feb; 266(2 Pt 2):F291-7. PubMed ID: 8141330
[TBL] [Abstract][Full Text] [Related]
25. Atrial natriuretic peptide and nitric oxide signaling antagonizes vasopressin-mediated water permeability in inner medullary collecting duct cells.
Klokkers J; Langehanenberg P; Kemper B; Kosmeier S; von Bally G; Riethmüller C; Wunder F; Sindic A; Pavenstädt H; Schlatter E; Edemir B
Am J Physiol Renal Physiol; 2009 Sep; 297(3):F693-703. PubMed ID: 19570884
[TBL] [Abstract][Full Text] [Related]
26. Effect of vasopressin on Na+ kinetics in cultured rat vascular smooth muscle cells.
Okada K; Ishikawa S; Saito T
Biochem Biophys Res Commun; 1990 Nov; 173(1):224-30. PubMed ID: 2124111
[TBL] [Abstract][Full Text] [Related]
27. Correlation between vascular and cellular responses to atrial natriuretic peptide and to sodium nitroprusside.
Newman WH; Zhang LM; Castresana MR; Currie MG; Becker BF
Life Sci; 1994; 54(18):1351-6. PubMed ID: 8190007
[TBL] [Abstract][Full Text] [Related]
28. Effect of sulindac on prostaglandin synthesis in human and in cultured rat renal and vascular smooth muscle cells.
Sato M; Abe K; Takeuchi K; Yasujima M; Akiu N; Saito T; Yoshinaga K
Tohoku J Exp Med; 1992 Jan; 166(1):185-200. PubMed ID: 1412444
[TBL] [Abstract][Full Text] [Related]
29. Down-regulation of protein kinase C potentiates atrial natriuretic peptide-stimulated cGMP accumulation in vascular smooth-muscle cells.
Kawabe J; Ohsaki Y; Onodera S
Biochim Biophys Acta; 1992 Dec; 1175(1):81-7. PubMed ID: 1362357
[TBL] [Abstract][Full Text] [Related]
30. Diuretics modify [Arg8]vasopressin-stimulated cAMP but not atrial natriuretic peptide-stimulated cGMP formation in renal cells.
Kanda K; Miyamoto N; Seo H; Ogawa K; Hatano T; Matsui N
Eur J Pharmacol; 1991 Jan; 192(1):153-9. PubMed ID: 1645672
[TBL] [Abstract][Full Text] [Related]
31. Atrial natriuretic peptide, oxytocin, and vasopressin increase guanosine 3',5'-monophosphate in LLC-PK1 kidney epithelial cells.
Leitman DC; Agnost VL; Catalano RM; Schröder H; Waldman SA; Bennett BM; Tuan JJ; Murad F
Endocrinology; 1988 Apr; 122(4):1478-85. PubMed ID: 2894298
[TBL] [Abstract][Full Text] [Related]
32. Atrial natriuretic peptide and cGMP inhibit Na+/H+ antiporter in vascular smooth muscle cells in culture.
Caramelo C; López-Farré A; Riesco A; Olivera A; Okada K; Cragoe EJ; Tsai P; Briner VA; Schrier RW
Kidney Int; 1994 Jan; 45(1):66-75. PubMed ID: 8127023
[TBL] [Abstract][Full Text] [Related]
33. Papillary collecting tubule responsiveness to atrial natriuretic factor in Dahl rats.
Appel RG; Dunn MJ
Hypertension; 1987 Jul; 10(1):107-14. PubMed ID: 3036700
[TBL] [Abstract][Full Text] [Related]
34. Effect of atrial natriuretic factor on Na+-K+-Cl- cotransport of vascular smooth muscle cells.
Owen NE; Bush EN; Holleman W; O'Donnell ME
Hypertension; 1987 Nov; 10(5 Pt 2):I128-30. PubMed ID: 2824361
[TBL] [Abstract][Full Text] [Related]
35. Effect of atrial natriuretic factor and fate of cyclic-guanosine-monophosphate in the rat kidney.
Syrén ML
Acta Physiol Scand; 1997 May; 160(1):1-7. PubMed ID: 9179304
[TBL] [Abstract][Full Text] [Related]
36. Atrial natriuretic peptide enhances IL-1 beta-stimulated nitric oxide production in cultured rat vascular smooth muscle cells.
Iimura O; Kusano E; Homma S; Takeda S; Ikeda U; Shimada K; Asano Y
Kidney Blood Press Res; 1998; 21(1):36-41. PubMed ID: 9661135
[TBL] [Abstract][Full Text] [Related]
37. Cardiac natriuretic peptides inhibit cyclosporine-induced production of endothelin in cultured rat mesangial cells.
Kohno M; Yokokawa K; Mandal AK; Horio T; Yasunari K; Takeda T
Metabolism; 1995 Mar; 44(3):404-9. PubMed ID: 7885289
[TBL] [Abstract][Full Text] [Related]
38. Possible mechanisms of age-associated reduction of vascular relaxation caused by atrial natriuretic peptide.
Moritoki H; Yoshikawa T; Hisayama T; Takeuchi S
Eur J Pharmacol; 1992 Jan; 210(1):61-8. PubMed ID: 1350988
[TBL] [Abstract][Full Text] [Related]
39. Variability of response to atrial natriuretic peptide and sodium nitroprusside in cultured vascular smooth muscle cells from three blood vessels.
Zhang LM; Castresana M; Newman WH
Crit Care Med; 1994 Sep; 22(9):1461-4. PubMed ID: 8062570
[TBL] [Abstract][Full Text] [Related]
40. C-natriuretic peptide but not atrial natriuretic peptide increases cyclic GMP in cerebral arterial smooth muscle cells.
Tao H; Zhang LM; Castresana MR; Shillcutt SD; Newman WH
Life Sci; 1995; 56(26):2357-65. PubMed ID: 7791522
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
